Magnus Financial Group LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Magnus Financial Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 05, 2020	SELL	$33.21 - $51.27 $262,923 - $405,904	-7,917 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$26.12 - $43.27 $5,459 - $9,043	-209 Reduced 2.57%	7,917 $342,000
Q1 2020 May 11, 2020	BUY	$20.56 - $63.12 $8,594 - $26,384	418 Added 5.42%	8,126 $234,000
Q2 2019 Aug 05, 2019	BUY	$17.43 - $28.82 $134,350 - $222,144	7,708 New	7,708 $204,000

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Magnus Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Magnus Financial Group LLC with notifications on news.